About APAC Precision Health Initiative

As an AI medical technology company driven by innovation at its core, we have built formidable expertise through years of deep commitment in two key domains: pharmaceutical R&D and medical imaging. In pharmaceuticals, we have accumulated extensive pharmaceutical intermediate reserves and proprietary research breakthroughs. In 2026, we are systematically initiating national patent applications to protect our core intellectual property, while advancing 'drug repurposing' research to uncover new indications and applications for existing compounds. In medical imaging, our self-developed AI-assisted diagnostic software delivers high-precision, intelligent image analysis, with NMPA certification underway in 2026 to ensure regulatory-compliant clinical deployment.

We pursue a dual-engine strategy of domestic synergy and international collaboration. Domestically, we are integrating with China General Technology Group's cloud-based medical imaging platform and partnering with China National United Corporation and Sinopharm Group to build a digital pharmaceutical wholesale and retail platform, driving intelligent, refined management of drug distribution. Internationally, we are actively advancing partnerships with global healthcare leaders such as Siemens, continuously expanding our global market presence.

In overseas markets, we have pioneered the deployment of AI-assisted medical imaging diagnostic services in underserved regions such as Timor-Leste, innovatively introducing a 'FHIR + GB/T' dual-standard data architecture that ensures compatibility between international standards (FHIR) and Chinese national standards (GB/T). This architecture not only elevates local diagnostic capabilities but also builds a bridge for cross-border medical data exchange, enabling seamless patient referrals across countries.

As global demand for cross-border healthcare continues to grow, we are forging our dual-standard data architecture into a core competitive advantage — positioning ourselves as the nexus connecting China's medical resources with the world, and truly fulfilling our mission of 'Medicine Without Borders.'